A New Direction in the Treatment of RAS-Mutant Cancers: Insights from Clinical Studies of daraxonrasib

Next-generation pan-RAS inhibitor daraxonrasib is showing promising clinical signals in RAS-mutant cancers, including pancreatic cancer and NSCLC, marking a new stage in precision oncology.

Top Stories

How AI Reshapes Drug R&D: A Full-Chain Innovation from Target Discovery to Clinical Trials

A Breakthrough in Nebulized Antiviral Therapy: Phase III Progress of Peramivir Inhalation Solution

Latest Coverage

Next-Generation MS Therapy Competition: BTK Inhibitors Are Reshaping the Landscape

How Pharmaceutical Distributors Respond to Transportation Requirements for Different Dosage Forms
As the global pharmaceutical supply chain continues to evolve, pharmaceutical transportation is no longer just about ...

Finerenone Approved for a New Indication in China: 18% Reduction in Heart Failure Events and New Progress in HFpEF Treatment
On May 21, 2026, German pharmaceutical company Bayer announced that its innovative drug Finerenone (Kerendia) has bee...

From Laboratory to Clinical Practice: The Translational Medicine Journey of Nanomedicine in Targeted Cancer Therapy
Nanomedicine is reshaping targeted cancer therapy through advanced drug delivery systems, precision-controlled treatm...

April 2026 Breakthroughs in Cancer Treatment: 26 New Projects Launched, Advances in Immunotherapy and Precision Targeting
Global oncology developments in April 2026 included 26 newly funded cancer research projects, advances in immunothera...

Spatial Biology: From 'Average Tumor' to 'Cell-Level Precision Therapy'
Tumor treatment is facing a profound paradigm shift.

In-Depth Analysis

A New Direction in the Treatment of RAS-Mutant Cancers: Insights from Clinical Studies of daraxonrasib

How AI Reshapes Drug R&D: A Full-Chain Innovation from Target Discovery to Clinical Trials

A Breakthrough in Nebulized Antiviral Therapy: Phase III Progress of Peramivir Inhalation Solution

Next-Generation MS Therapy Competition: BTK Inhibitors Are Reshaping the Landscape